Federal contract award
75N95023C00016
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE CONTROLS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $2.5M |
| Current contract value | $2.5M |
| Potential contract value / ceiling | $9.7M |
| Start date | Aug 23, 2023 |
| Current end date | Aug 22, 2027 |
| Potential end date | Aug 22, 2028 |
| Latest award activity | Aug 7, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 7, 2026 | P00009 | $621.9K | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Sep 19, 2025 | P00008 | $0 | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Aug 22, 2025 | P00007 | $614.8K | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Jun 17, 2025 | P00006 | $0 | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Jan 31, 2025 | P00005 | $0 | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Sep 27, 2024 | P00004 | $0 | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Sep 26, 2024 | P00003 | $0 | NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE |
| Aug 23, 2024 | P00002 | $614.8K | CLINICAL SITE FOR THE NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) THAT COLLECTS, STORES, AND PROVIDES CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS |
| Sep 14, 2023 | P00001 | $122.1K | THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE CONTROLS. |
| Aug 22, 2023 | 0 | $553.7K | THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE CONTROLS. |
Estimated positioning window
Aug 22, 2027 – Feb 22, 2028
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2028-08-22 (660 days from calculation)
- +25 points
- 25 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-08-07
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | Sep 7, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | Sep 7, 2022 |
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | Jul 22, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | Jul 22, 2022 |
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | Jul 14, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | Jul 14, 2022 |
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | Jul 14, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | Jul 14, 2022 |
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | Jul 7, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | Jul 7, 2022 |
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | Jun 30, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | Jun 30, 2022 |
| Kristina Jenkins | Contact | kristina.jenkins@nih.gov | Source | May 12, 2022 |
| Christine Frate | Contact | christine.frate@nih.gov | Source | May 12, 2022 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.